Verdict84/ 100
Ranked #9 · Grade BEditorial review
Henry Meds review
A flat-fee compounded pioneer — simple model, but priced at the higher end now.
Visit Henry Meds Editorial review — no commercial relationship.
- Semaglutide
- $249/mo
- Tirzepatide
- $349/mo
- Coverage
- Multi-state
- Brand-name
- Compounded only
The scorecard
Henry Meds scored on our six published factors. See the methodology.
Real-world results85/100
Price honesty85/100
Prescriber access84/100
Formulary choice82/100
Cancellation fairness84/100
Member support84/100
What we like
- Simple flat-fee model
- Well-established brand
- Both molecules
The caveats
- Higher pricing than many newer entrants
- Compounded only
The verdict
Best for: People who want a simple, well-known flat-fee compounded program. A flat-fee compounded pioneer — simple model, but priced at the higher end now.
Pricing, states and verification reflect Henry Meds's public disclosures at last review; the Verdict Score is our editorial judgment per the methodology. Prices change — confirm on Henry Meds's site. Not medical advice; see our disclosure.